Compare CCEL & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | LOAN |
|---|---|---|
| Founded | 1989 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 38.8M |
| IPO Year | 2022 | 1999 |
| Metric | CCEL | LOAN |
|---|---|---|
| Price | $5.40 | $3.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.6K | ★ 23.9K |
| Earning Date | 10-09-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 13.46% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.23 | ★ 0.32 |
| Revenue | ★ $25,384,279.00 | $8,666,307.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.43 | ★ $10.16 |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $3.19 |
| 52 Week High | $5.45 | $5.01 |
| Indicator | CCEL | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 29.12 |
| Support Level | $3.05 | N/A |
| Resistance Level | $5.45 | $4.50 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 48.21 | 6.45 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.